Key result
ACE inhibitors improve post-MI prognosis, especially with left ventricular dysfunction or diabetes.
Why the study?
The use of ACE inhibitors in patients after prior myocardial infarction to improve prognosis was analyzed based on controlled studies.
Do angiotensin-converting enzyme (ACE) inhibitors improve prognosis in patients after prior myocardial infarction?
Do angiotensin-converting enzyme (ACE) inhibitors improve prognosis in patients after prior myocardial infarction?
ACE inhibitors are strongly recommended for post-myocardial infarction patients, particularly those with left ventricular dysfunction or diabetes, to improve prognosis.
May warrant ACE inhibitor consideration post-MI in high-risk subgroups; leaves open need for contemporary randomized confirmation.
The paper analyzes the use of angiotensin-converting enzyme (ACE) inhibitors in patients after prior myocardial infarction. It presents the data of controlled studies, which indicate that it is warranted to use ACE inhibitors to improve prognosis in patients. It is concluded that it is unreasonable for a physician not to prescribe ACE inhibitors to post-myocardial infarction patients with obvious or asymptomatic left ventricular dysfunction and to diabetic patients (if no contraindications).
No takes yet. Share an insight, caveat, or question.
Albert S. Galyavich (2010) conducted a review in Post-myocardial infarction. Angiotensin-converting enzyme (ACE) inhibitors was evaluated on Prognosis. ACE inhibitors are warranted to improve prognosis in post-myocardial infarction patients, particularly those with left ventricular dysfunction or diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: